Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 2/2018

01-04-2018 | Original Article

Lower Total Leukocyte and Neutrophil Counts in Healthy Young Africans from Uganda

Authors: Ritesh Goswami, Naveen Kakkar, M. Joseph John

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2018

Login to get access

Abstract

The total leukocyte count (TLC) is an important component of the complete blood count and influences many clinical decisions. The effect of race or ethnicity on TLC is not well known. The African population has been reported to have lower than normal TLC and neutrophil counts. In this study, thirty eight African students referred for medical check up to a tertiary care hospital were included. Complete blood count was done on a three part automated hematology analyzer. Blood smear examination and manual differential count was also done. The control group included 38 age and sex matched healthy individuals. Student t test was used to compare the differences between the groups. The mean TLC in African students (4.95 ± 1.09 × 109/l) was significantly lower (p < 0.0001) than that seen in the control group (7.42 ± 1.7 × 109/l). The mean neutrophil percentage was also lower (49 ± 7.5%) in African students compared to the control group (63.6 ± 9.8%) [p < 0.0001] while lymphocyte percentage was higher (45.2 ± 7.5%) in the African students as compared to the control group (31.0 ± 9.3%) [p < 0.0001]. Absolute neutrophil count was also lower (2.45 ± 0.76 × 109/l) in African students compared to the control group (4.76 ± 1.47 × 109/l) while absolute lymphocyte count was comparable (2.21 ± 0.5 × 109/l vs. 2.26 ± 0.72 × 109/l) [p = 0.7212]. This study has shown lower leukocyte and neutrophil counts in apparently healthy African individuals. Knowledge of this variation from normal white cell and neutrophil counts is important in avoiding unnecessary investigations and influencing therapeutic decisions in these individuals.
Literature
1.
go back to reference Bates I, Lewis SM (2012) Reference ranges and normal values. In: Bain BJ, Bates I, Laffan MA, Lewis SM (eds) Dacie and Lewis Practical Haematology, 11th edn. Elsevier, Amsterdam, pp 11–22CrossRef Bates I, Lewis SM (2012) Reference ranges and normal values. In: Bain BJ, Bates I, Laffan MA, Lewis SM (eds) Dacie and Lewis Practical Haematology, 11th edn. Elsevier, Amsterdam, pp 11–22CrossRef
2.
go back to reference Paz Z, Nails M, Ziv E (2011) The genetics of benign neutropenia. Isr Med Assoc J 13:625–629PubMed Paz Z, Nails M, Ziv E (2011) The genetics of benign neutropenia. Isr Med Assoc J 13:625–629PubMed
3.
go back to reference Haddy TB, Rana SR, Castro O (1999) Benign ethnic neutropenia: what is a normal absolute neutrophil count? J Lab Clin Med 133:15–22CrossRefPubMed Haddy TB, Rana SR, Castro O (1999) Benign ethnic neutropenia: what is a normal absolute neutrophil count? J Lab Clin Med 133:15–22CrossRefPubMed
5.
go back to reference Mason BA, Lessin L, Schechter GP (1979) Marrow granulocyte reserves in black Americans: hydrocortisone-induced granulocytosis in the “benign” neutropenia of the black. Am J Med 67:201–205CrossRefPubMed Mason BA, Lessin L, Schechter GP (1979) Marrow granulocyte reserves in black Americans: hydrocortisone-induced granulocytosis in the “benign” neutropenia of the black. Am J Med 67:201–205CrossRefPubMed
6.
go back to reference Hsieh MM, Tisdale JF, Rodgers GP, Young NS, Trimble EL, Little RF (2010) Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy? J Clin Oncol 28:1633–1637CrossRefPubMedPubMedCentral Hsieh MM, Tisdale JF, Rodgers GP, Young NS, Trimble EL, Little RF (2010) Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy? J Clin Oncol 28:1633–1637CrossRefPubMedPubMedCentral
7.
go back to reference Grann VR, Ziv E, Joseph CK, Neugut AI, Wei Y, Jacobson JS et al (2008) Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br J Haematol 143:288–293CrossRefPubMedPubMedCentral Grann VR, Ziv E, Joseph CK, Neugut AI, Wei Y, Jacobson JS et al (2008) Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br J Haematol 143:288–293CrossRefPubMedPubMedCentral
8.
go back to reference Thobakgale CF, Ndung’u T (2014) Neutrophil counts in persons of African origin. Curr Opin Hematol 21:50–57CrossRefPubMed Thobakgale CF, Ndung’u T (2014) Neutrophil counts in persons of African origin. Curr Opin Hematol 21:50–57CrossRefPubMed
9.
go back to reference D’Angelo G (2009) Ethnic and genetic causes of neutropenia: clinical and therapeutic implications. Lab Hematol 15:25–29CrossRefPubMed D’Angelo G (2009) Ethnic and genetic causes of neutropenia: clinical and therapeutic implications. Lab Hematol 15:25–29CrossRefPubMed
10.
go back to reference Reed WW, Diehl LF (1991) Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks. Arch Intern Med 151:501–505CrossRefPubMed Reed WW, Diehl LF (1991) Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks. Arch Intern Med 151:501–505CrossRefPubMed
11.
go back to reference Freedman DS, Gates L, Flanders WD, Van Assendelft OW, Barboriak JJ, Joesoef MR et al (1997) Black/white differences in leukocyte subpopulations in men. Int J Epidemiol 26:757–764CrossRefPubMed Freedman DS, Gates L, Flanders WD, Van Assendelft OW, Barboriak JJ, Joesoef MR et al (1997) Black/white differences in leukocyte subpopulations in men. Int J Epidemiol 26:757–764CrossRefPubMed
12.
go back to reference Hsieh MM, Everhart JE, Byrd-Holt DD, Tisdale JF, Rodgers GP (2007) Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med 146:486–492CrossRefPubMed Hsieh MM, Everhart JE, Byrd-Holt DD, Tisdale JF, Rodgers GP (2007) Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med 146:486–492CrossRefPubMed
13.
go back to reference Grann VR, Bowman N, Joseph C, Wei Y, Horwitz MS, Jacobson JS et al (2008) Neutropenia in 6 ethnic groups from the Caribbean and the U.S. Cancer 113:854–860CrossRefPubMed Grann VR, Bowman N, Joseph C, Wei Y, Horwitz MS, Jacobson JS et al (2008) Neutropenia in 6 ethnic groups from the Caribbean and the U.S. Cancer 113:854–860CrossRefPubMed
15.
16.
go back to reference Bain B, Seed M, Godsland I (1984) Normal values for peripheral blood white cell counts in women of four different ethnic origins. J Clin Pathol 37:188–193CrossRefPubMedPubMedCentral Bain B, Seed M, Godsland I (1984) Normal values for peripheral blood white cell counts in women of four different ethnic origins. J Clin Pathol 37:188–193CrossRefPubMedPubMedCentral
17.
go back to reference Mantzaris I, Yu Y, Msaouel P, Lam AP, Janakiram M, Friedman EW et al (2016) Analysis of overall survival in a large multiethnic cohort reveals absolute neutrophil count of 1100 as a novel prognostic cutoff in African Americans. Oncotarget 7:67948–67955CrossRefPubMedPubMedCentral Mantzaris I, Yu Y, Msaouel P, Lam AP, Janakiram M, Friedman EW et al (2016) Analysis of overall survival in a large multiethnic cohort reveals absolute neutrophil count of 1100 as a novel prognostic cutoff in African Americans. Oncotarget 7:67948–67955CrossRefPubMedPubMedCentral
Metadata
Title
Lower Total Leukocyte and Neutrophil Counts in Healthy Young Africans from Uganda
Authors
Ritesh Goswami
Naveen Kakkar
M. Joseph John
Publication date
01-04-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0866-0

Other articles of this Issue 2/2018

Indian Journal of Hematology and Blood Transfusion 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine